Evidence from preclinical and clinical studies suggests heterogeneous effects of GLP1RAs on cancer risk: the incidence of hepatocellular, oesophageal, endometrial, ovarian and prostate cancers might be reduced, whereas safety concerns persist with respect to thyroid (both medullary and non-medullary) carcinomas
The full investigation by Sara Talpos, is available at statnews.com
CrossRef Gadoxetate-enhanced MRI Transitional Phase Parenchymal Signal: Effect on Washout and LI-RADS Diagnostic Performance for Hepatocellular Carcinoma Seong Hyeon Cho, Yong Jun Jung, Seung Baek Hong, Se Jin Choi, Seung Soo Lee, Jae Ho Byun, Hyung Jin Won, Yong Moon Shin, Subin Heo, Sang Hyun Choi Radiology .2026;[Epub] CrossRef Hepatocellular carcinoma: current aspects of multidisciplinary management

Comprehensive Hormone Testing Mood, Memory & Sleep Support Hot Flash & Night Sweat Relief Weight Gain & Metabolism Reset Plans Advanced Therapies When Needed Body Composition + Strength Goals Targeted Nutrition Protocols Bio-Identical Hormone Therapy (BHRT) Personalized Supplement Regimens Comprehensive Hormone Lab Testing Cycle Mapping & Ovulation Tracking Fertility Foundations Plan Period Repair Protocols Post-Birth Control Recovery Plans Custom Nutrition & Anti-Inflammatory Plans Targeted Supplement Guidance Full PCOS Root-Cause Evaluation Functional Lab Testing Metabolic Strategy for Muscle + Hormone Sync Performance-Driven Nutrition Planning Cycle-Syncing for Training & Recovery Targeted Supplement Protocols Body Composition + Strength Goals Fertility-Respecting Options Holistic Weight loss Semiglutide, Trizepitide, B12) Peptide Therapies : Like BPC-157, MOTS-c, CJC/Ipamorelin) to support healing, cellular repair, muscle growth, and fat metabolism
&srotate=0)
This chronological summary highlights major historical milestones from the incretin concept through to the current generation of GLP-1-based therapies and their impacts